April 4th, 2011
STICH Illuminates CABG in Heart Failure, Finally
Larry Husten, PHD
After a very long wait, the Surgical Treatment for Ischemic Heart Failure (STICH) trial has finally shed light on the common but poorly understood use of CABG in heart failure patients with ischemic heart disease. The results were presented by Eric Velazquez at the ACC and published simultaneously in the New England Journal of Medicine. […]
April 4th, 2011
MitraClip Compared with Surgery in EVEREST II
Larry Husten, PHD
The final results of the highly anticipated EVEREST (Endovascular Valve Edge-to-Repair Study) II were presented by Ted Feldman at the ACC Scientific Sessions in New Orleans and published simultaneously in the New England Journal of Medicine. Some 279 patients with moderately severe or severe mitral regurgitation (MR) were randomized on a 2:1 basis to either […]
April 3rd, 2011
The Cardiology Profession: At the Table or on the Menu?
Sandeep Mangalmurti, MD, JD
Several Cardiology Fellows who are attending ACC.11 this week are blogging together on CardioExchange. The Fellows include Sandeep Mangalmurti, Hansie Mathelier, John Ryan (moderating and providing an outsider’s view from Chicago), Amit Shah, and Justin Vader. See the previous post in this series, and check back often to learn about the biggest buzz in New […]
April 3rd, 2011
2-Year Outcomes of the RESOLUTE All Comers Trial
Larry Husten, PHD
The Resolute zotarolimus-eluting stent (ZES) is now starting to demonstrate good long-term results. At an interventional featured clinical study session at the ACC in New Orleans and in a simultaneous publication in the Lancet, Sigmund Silber and colleagues presented the 2-year findings of the RESOLUTE All Comers trial comparing the ZES with the Xience V […]
April 3rd, 2011
PARTNER B Substudy Examines Cost-Effectiveness of TAVI
Larry Husten, PHD
Transcatheter aortic valve implantation (TAVI) is about as cost-effective as other common cardiovascular procedures, according to results of the PARTNER B cost-effectiveness substudy, which were presented today at the American College of Cardiology meeting in New Orleans. (The main results of PARTNER B, which studied the safety and efficacy of TAVI in patients with severe […]
April 3rd, 2011
From Far in the Future to the Here and Now: Reflections on the Translational Research Symposium and a Session on VADs
Justin M Vader, M.D.
Several Cardiology Fellows who are attending ACC.11 this week are blogging together on CardioExchange. The Fellows include Sandeep Mangalmurti, Hansie Mathelier, John Ryan (moderating and providing an outsider’s view from Chicago), Amit Shah, and Justin Vader. See the next post in this series, and check back often to learn about the biggest buzz in New […]
April 3rd, 2011
PARTNER A: TAVI Noninferior to Surgery, but Stroke Might Be a Problem
Larry Husten, PHD
Here are the main results of the much anticipated PARTNER A trial comparing transcatheter aortic valve implantation (TAVI) versus surgery for aortic valve replacement (AVR). They were presented this morning in New Orleans at the ACC. Some 699 high-risk older patients with severe aortic stenosis were randomized to either TAVI or AVR. The primary endpoint, […]
April 3rd, 2011
TAVI: PARTNER or Blind Date?
Richard A. Lange, MD, MBA
Almost 700 patients with severe aortic stenosis who were considered “high risk” for conventional valve replacement (AVR) were randomized to transcatheter aortic valve implantation (TAVI) or AVR. In comparison to AVR, TAVI was associated with a higher incidence of stroke (5.1% vs 2.4% at one year), vascular complications (11.0% vs 3.2% at 30 days), and […]
April 1st, 2011
Who’s Paying for the Fellows?
John Ryan, MD
Several Cardiology Fellows who are attending ACC.11 this week are blogging together on CardioExchange. The Fellows include Sandeep Mangalmurti, Hansie Mathelier, John Ryan (moderating and providing an outsider’s view from Chicago), Amit Shah, and Justin Vader. See the next post in this series, and check back often to learn about the biggest buzz in New […]